Formulations comprising fn3-sirna conjugates and uses thereof

WO2025245474A1PCT designated stage Publication Date: 2025-11-27ARO BIOTHERAPEUTICS CO
-1 Cites 0 Cited by

Patent Information

Application Number
PCT/US2025/030821
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-23
Filing Date
2025-05-23
Publication Date
2025-11-27

Smart Images

  • Figure US2025030821_27112025_PF_FP_ABST
    Figure US2025030821_27112025_PF_FP_ABST
Patent Text Reader

Abstract

Provided for herein are pharmaceutical formulations comprising polypeptide-oligonucleotide conjugates, such as FN3 domain-siRNA conjugates.
Need to check novelty before this filing date? Find Prior Art